Influenza A virus-mediated priming enhances cytokine secretion by human dendritic cells infected with Streptococcus

Thomas Kuri1, Anna Smed Sörensen, Saskia Thomas

  • 1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

Cellular Microbiology
|February 21, 2013
PubMed

Insights

Influenza A virus primes immune cells, leading to increased IL-12p70 and IL-6 production upon secondary Streptococcus pneumoniae infection. Type I interferons are key drivers of this priming effect.

Area of Science:

  • Immunology
  • Virology
  • Microbiology

Background:

  • Secondary bacterial infections, particularly with Streptococcus pneumoniae (SP), following influenza A virus (IAV) infection pose significant global health challenges.
  • The precise mechanisms underlying the exacerbated disease progression during these co-infections remain incompletely understood.

Purpose of the Study:

  • To investigate the impact of IAV and SP co-infection on human monocyte-derived dendritic cells (MDDCs).
  • To analyze the expression of key pro-inflammatory and immune-modulatory cytokines in response to these infections.

Main Methods:

  • Analysis of cytokine expression (IL-12p70, IL-6) in MDDCs following IAV and/or SP infection.
  • Investigation of factors influencing cytokine production, including time, dose, duration, pathogen viability, bacterial uptake, and endosome acidification.
  • Assessment of the role of type I interferons in the observed immune response.

Main Results:

  • IAV infection or exposure to IAV-infected cell supernatants primed MDDCs, enhancing IL-12p70 and IL-6 production upon subsequent SP infection.
  • This priming effect was independent of simultaneous co-infection but dependent on infection parameters and bacterial factors.
  • Bacterially infected cells were identified as the primary producers of IL-12p70.
  • Type I interferons were identified as the main mediators responsible for IAV-induced priming of IL-12p70.

Conclusions:

  • IAV infection primes dendritic cells, altering their cytokine response to subsequent SP infection, which may explain elevated cytokine levels in co-infected patients.
  • Type I interferons play a crucial role in mediating this priming effect.
  • These findings offer insights into the pathogenesis of IAV-SP co-infections and their clinical implications.